We Are Lumira Ventures
Our mission is to deliver exceptional returns for investors by investing in and helping to create value in transformative life sciences companies. In achieving this goal, we have consistently built companies delivering impact to patients and healthcare systems worldwide.
Investing With Purpose
Mission-Driven Founders
We partner with founders and diverse teams that are passionate about delivering transformative therapeutic products for patients.
Value Adding Relationships
We are engaged partners, leveraging the strength of our experience and broad network, to work closely with co-investors and management teams to maximize the value, growth, and impact of our companies.
The Right Way
We ensure each investment is done the right way - based on a process of sound diligence, collaboration, and encouraging alternative views, while ultimately being tied to a consensus decision that aligns with our investment objectives.
Strategic Partners
We utilize the deep relationships within our network to facilitate our due diligence and value-added processes, to provide our companies with the incremental insights, tools, and opportunities they need to succeed.
Our Focus
Modality: Therapeutic products and medical devices
Stage: Across the development continuum for therapeutics and late clinical to revenue generating for medical device
Therapeutic Area: We invest in a broad range of indications with high unmet clinical need
Transforming therapeutics to make a difference in patient health
Reviving Neurons Restoring Control
Bright Angel Therapeutics is Startup in Toronto
We all know about the condition of heart failure. We just haven’t been able to treat it the right way—until now.
Transforming the Treatment of Heart Failure
Ignite Your Senses, Rediscover Smell and Taste
We can build a Diakine™ for every patient.
Signaling a new era in T2D therapy
The Practical Solution.
Minimally Invasive Isn't Minimal Enough
Building a Better Future for Alzheimer’s Patients
A Leading Innovative Specialty Pharmaceutical Company
Notch is building best-in-class T cell therapies.
Developing Next Generation Gene Editing Technologies
We will relentlessly pursue precision treatments targeting SGK1 to enable people to live their absolute best lives.Without Limits.
Enabling a better future for people with rare immune disorders
Proactive. Comprehensive.
CHANGING THE TRAJECTORY OF AUTOIMMUNE DISEASES
Next Generation Cancer Therapies
Novel biologics for diseases with unmet need
Organizing the world's health knowledge so that everyone gets the best care
Harnessing the Power of Radiopharmaceuticals
Stopping Cancer Before It Starts
Degrading proteins. Saving lives.
BREAKTHROUGH IN NEUROMODULATION
From topology to treatments
First-In-Class Therapies Designed to Reprogram the Immune System
Restoring cognitive functions across brain disorders
Novel Experimental Treatments for Immune and Inflammatory Diseases
Mainstreaming Gene Therapy
Next-Generation Radiopharmaceuticals for precision medicine
Pioneering Tomorrow’s Cures, Today.
Breakthrough antibody discovery for breakthrough therapeutics
Charging forward
22 Strathmore Road, Suite 115, Natick, MA 01760
Image Without Compromise.
Transformational therapies for neurodegenerative and aging-related diseases
Gene therapy for advanced coronary artery disease
Precision Heart Monitoring Made Simple
Making a Meaningful Difference
Developing the Next Generation of Treatments for Prostate Cancer
Pioneering biotherapeutic delivery for the prevention and treatment of chronic lung disease
Lumira Ventures is proud to introduce the newest cohort joining our Venture Innovation Program (VIP) for the 2024-2025 term. The … More
Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.
We found a number of people with your first name. When you find your first name in this list, select it